Learning lessons from lipids to make COVID-19 vaccines.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 35385689.
- Also identified by DOI 10.1016/j.cell.2022.03.026 and PMC identifier 8979763.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A game-changing intervention in the COVID-19 pandemic has been the rapid implementation of highly effective vaccines against SARS-CoV-2. The 2022 Canada Gairdner International Award recognizes Pieter Cullis, Katalin Karikó, and Drew Weissman "for their pioneering work developing nucleoside-modified mRNA and lipid nanoparticle (LNP) drug delivery: the foundational technologies for the highly effective COVID-19 mRNA vaccines." Cell editor Cheri Sirois caught up with Pieter to discuss how a long interest in basic and applied questions in lipid biology led to this fortuitous collaboration. Excerpts of the conversation are presented below.
Medical subject headings
- COVID-19 Vaccines
- Liposomes
- Nanoparticles